Newest Issue is Out. Get your exclusive copy today.

Subscribe for Free

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

01

Dec 2020

Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Shanghai Stock Exchange listed company HitGen Incannounced that it has entered into a research collaboration agreement with Cedilla Therapeutics Inc Cedilla a private biotechnology company developing targeted small molecules for the treatment of cancer and other diseases caused by protein dysregulat...

01

Dec 2020

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

Telix Pharmaceuticals Limited announces it has entered into an agreement with Scintec Diagnostics GmbH Scintec to acquire TheraPharm GmbH TheraPharm a SwissGerman biotechnology company developing innovative diagnostic and therapeutic solutions in the field of hematology

30

Nov 2020

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients announced a supply agreement with the UK government for an additional million doses of mRNA

27

Nov 2020

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

Egle Therapeutics SAS Egle an emerging biotechnology company focused on developing firstin class immunotherapies targeting immune suppressor regulatory Tcells Tregs for oncology and autoimmune diseases today announces that it has achieved the first milestone in its strategic research alliance with T...

press releasesRead more...

01

Dec 2020

Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)

Aprea Therapeutics Inc a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the mutant tumor suppressor protein p announced that the US Food and Drug Administration FDA has granted Fast Track designation for eprenetapopt in the treatment of...

01

Dec 2020

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

Biotechnology frontrunner LuminUltra announced the acquisition of Source Molecular Corporation a leader in labbased testing solutions for microbial source tracking of pathogens including SARSCoV the virus that causes COVID With this acquisition LuminUltra has further expanded its range of molecular...

01

Dec 2020

MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab

MacroGenics Inc a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer announced that it has partnered with EVERSANA a pioneer of nextgeneration commercial services to the global life sciences indu...

30

Nov 2020

Veritas offers genome analysis to predict a person's response to COVID-19

Genetic factors can determine a persons possible response to infection regardless of age and previous illnesses By analyzing it we can better understand why certain people have little or no symptoms while others experience severe complications

EventsRead more...

30 - 03

Nov 2020

Gene Therapy Analytical Development 2020

Philadelphia

30 - 03

Nov 2020

2nd Gene Therapy Analytical Development Summit

Hanson Wade
online

30 - 02

Nov 2020

LEAP HR Emerging Biopharma 2020

Hilton Boston Back Bay

01 - 02

Dec 2020

Pharmaceutical Cold Chain Management

Mövenpick Hotel Riyadh

Thermo Fisher Scientific - Chromatography Solutions

KNOWLEDGE BANK

Interviews

GE Healthcare

President & CEO
Our current business focus and strengths are in the areas of bioprocessing proteins cellular analysis cell handling and tools for cell therapy Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provide We are particularly excited about the sample collection and storage opportunity with the FTA product lineWe have a stron...

Articles

Advanced Nanobots for ‘Programmed’ Biomedical Applications

The idea of nanobots that could perform programmed tasks at targeted sites by traveling through biological fluids is no more in science fiction now Recent development in the field of nanotechnology provides the scope of designing miniaturised tiny nanobots which are even smaller than the dimension of biological cells

Research Insights

Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics

Abstract Mycobacterium tuberculosis M tuberculosis is considered innately resistant to lactam antibiotics However there is evidence that susceptibility to lactam antibiotics in combination with lactamase inhibitors is variable among clinical isolates and these may present therapeutic options for drugresistant cases Here we report o

Case Studies

Heat Stable Hepatitis B vaccine

Partner Since Arecor has collaborated with PATH an international global health nonprofit organisation on the development of heat stable vaccines using the ArestatT technology Stabilisation of hepatitis B vaccine one of the many vaccines successfully st

Techno Trends

Pall Corporation's Flexible Containment System to Ensure Workers' Safety

To protect the workers and the surrounding environment from exposure to harmful compounds Pall Corporation has introduced a flexible system called GBK Containment system which will ensure safe handling of potent compounds As new and more hazardous APIs are entering the pipeline companies are facing an increasing challenge to ensure their workers safety It is estimated...

White Papers

NextGen Pharma Takes ‘Smart’ Strides with Internet of Things

Abstract Digitization of processes and data across the value chain along with the emergence of Internet of Things IoT has transformed the Pharma industry Although IoT is still in the nascent stage of adoption in the Life Sciences industry the use of smart devices and machinetomachine MM communication leveraging SMAC technologies comes at a time when

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

Natural Intelligence

Despite the hype the routine use of AI in marketing in the life sciences is a long way away

RESEARCH DEVELOPMENT

OCULAR DRUG DELIVERY PERSPECTIVE

As per the estimation of a Forbes analysis around US billion is spent by large pharmaceutical companiesfor a single drug approval

CLINICAL TRIALS

CLINICAL TRIALS IN A PETRI DISH

Clinical trials include experiments and the related observations done in clinical settings as part of prospective biomedical research studies on human...

MANUFACTURING

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The constant requirement for the targeted delivery of therapeutically active agents has been the key driver in particle engineering and processing wit...

Information Technology

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

The cyberphysical security is no longer an area that should be overlooked Unfortunately cyberphysical attacks of all kinds may cost companies a great...

EXPERT Talk

PHARMA LOGISTICS TRENDS

Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

01

Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

01

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

30

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

27

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

press releasesRead more...

01

Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)

01

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

01

MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab

30

Veritas offers genome analysis to predict a person's response to COVID-19

EventsRead more...

30 - 03

Gene Therapy Analytical Development 2020

30 - 03

2nd Gene Therapy Analytical Development Summit

30 - 02

LEAP HR Emerging Biopharma 2020

01 - 02

Pharmaceutical Cold Chain Management

TOP ARTICLES

1

Are We Ready to Ship Billions of COVID Vaccines Worldwide?

2

Personalised Therapy

3

Standard Operating Protocol (SOP) for The Clinical Diagnosis of Novel Coronavirus(COVID-19) Infection

4

Luminescent Carbon Dots: An Emerging Nanomedicine to Treat Antibiotic Resistant Bacterial Infections

5

Electronic Counters for Bottle Filling

KNOWLEDGE BANK

GE Healthcare

Advanced Nanobots for ‘Programmed’ Biomedical Applications

Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to &beta;-lactam Antibiotics

Heat Stable Hepatitis B vaccine

Pall Corporation's Flexible Containment System to Ensure Workers' Safety

NextGen Pharma Takes ‘Smart’ Strides with Internet of Things

Advisory Board

EDITORIAL SECTION

Natural Intelligence

OCULAR DRUG DELIVERY PERSPECTIVE

CLINICAL TRIALS IN A PETRI DISH

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

PHARMA LOGISTICS TRENDS

Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics